Lifeboat Foundation

The interaction of solids with high-intensity ultra-short laser pulses has enabled major technological breakthroughs over the past half-century. On the one hand, laser ablation of solids offers micromachining and miniaturization of elements in medical or telecommunication devices. On the other hand, accelerated ion beams from solids using intense lasers may pave the way for new opportunities for cancer treatment with laser-based proton therapy, fusion energy research, and analysis of cultural heritage.

Remember all those low rate scifi horror movies with big snakes, let’s see if the bookie will take bet on when we have a first big one (on the run from the facility)

Scientists used CRISPR editing to make the world’s first genetically modified snakes, giving new insight into how the reptiles develop their patterned scales.

Following the landmark approval of the first CRISPR-based cell therapy in December 2023, the CRISPR community is looking ahead to the next wave of commercial successes, fueled by continued innovation in the development of new gene editing and delivery tools and technologies. Equally exciting advances are occurring in livestock editing, xenotransplantation, and many other specialties.

In The State of CRISPR and Gene Editing virtual summit, GEN proudly gathers a tantalizing line-up of luminaries from academia and industry to discuss the latest research developments, innovations, and advanced technologies that are expanding the CRISPR toolbox, delivering new therapies to patients and safeguarding our food supply.

Cells in the human body chat with each other all the time. One major way they communicate is by releasing tiny spheres called exosomes. These carry fats, proteins, and genetic material that help regulate everything from pregnancy and immune responses to heart health and kidney function.

Now, a new Columbia University study in Nature Nanotechnology demonstrated that these “nanobubbles” can deliver potent immunotherapy directly to tough-to-treat lung cancer tumors via inhalation.

“Exosomes work like text messages between cells, sending and receiving information,” said lead researcher Ke Cheng, PhD, professor of biomedical engineering at Columbia. “The significance of this study is that exosomes can bring mRNA-based treatment to lung cancer cells locally, unlike systemic chemotherapy that can have side effects throughout the body. And inhalation is totally noninvasive. You don’t need a nurse to use an IV needle to pierce your skin.”

Scientists have recently discovered thousands of active RNA molecules that can control the human body.

By Philip Ball

Thomas Gingeras did not intend to upend basic ideas about how the human body works. In 2012 the geneticist, now at Cold Spring Harbor Laboratory in New York State, was one of a few hundred colleagues who were simply trying to put together a compendium of human DNA functions. Their ­project was called ENCODE, for the Encyclopedia of DNA Elements. About a decade earlier almost all of the three billion DNA building blocks that make up the human genome had been identified. Gingeras and the other ENCODE scientists were trying to figure out what all that DNA did.

In a scientific breakthrough, Mount Sinai researchers have revealed the biological mechanisms by which a family of proteins known as histone deacetylases (HDACs) activate immune system cells linked to inflammatory bowel disease (IBD) and other inflammatory diseases.

This discovery, reported in Proceedings of the National Academy of Sciences (PNAS), could potentially lead to the development of selective HDAC inhibitors designed to treat types of IBD such as ulcerative colitis and Crohn’s disease.

“Our understanding of the specific function of class II HDACs in different cell types has been limited, impeding development of therapies targeting this promising drug target family,” says senior author Ming-Ming Zhou, PhD, Dr. Harold and Golden Lamport Professor in Physiology and Biophysics and Chair of the Department of Pharmacological Sciences at the Icahn School of Medicine at Mount Sinai. “Through our proof-of-concept study, we’re unraveling the mechanisms of class II HDACs, providing essential knowledge to explore their therapeutic potential for safer and more effective disease treatments.”

Dr. Petr Cígler and his collaborators are working on refining molecular systems for transporting ribonucleic acid (RNA) molecules into cells. The question of how to effectively deliver RNA to a designated place in the body in order to silence a malfunctioning gene is one of the greatest challenges of the rapidly developing field of gene medicine.

Safe and high-quality fertility preservation is of growing significance for women in clinical trials. Current primary methods for cryopreserving human oocytes are slow freezing and vitrification, but existing techniques pose risks of biochemical toxicity and are restricted in large-scale clinical practice.

From Stanford, Albert Einstein, & Johns Hopkins U: a multimodal agent benchmark to evaluate AI in simulated clinical environments.

From stanford, albert einstein, & johns hopkins U

AgentClinic: a multimodal agent benchmark to evaluate AI in simulated clinical environments abs: https://arxiv.org/abs/2405.07960 project page: https://agentclinic.github.io code: https://github.com/samuelschmidgall/agentclinic.

Continue reading “SamuelSchmidgall/AgentClinic: Agent benchmark for medical diagnosis” »